Cellectar Biosciences, Inc. (CLRB) Form 8-K — Jul 10, 2026
$CLRBForm 8-KItems 5.02, 5.07, 9.01Filed Jul 10, 2026, 8:00 AM ET0001104659-26-082719Original filing
Cellectar Biosciences stockholders approved several proposals at the 2026 Annual Meeting held on July 7, including the election of two Class III directors and the ratification of the company's independent auditor. The meeting also saw the approval of an amendment to the 2021 Stock Incentive Plan, increasing the number of shares reserved for issuance by 2,000,000 shares to support future equity compensation grants.
Key figures
- Plan shares increase
- 2000000
- Warrant shares authorized
- 39618078
Price after filing
1 day: 0.0%7 days: -11.0%30 days: -8.9%
Close on the filing date to close N calendar days later (from $2.82). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.